Stockscreener 앱 받기
0.4527
6.43%
-0.0311
시장 영업 전:
.45
-0.0027
-0.60%
전일 마감가:
$0.4838
열려 있는:
$0.47
하루 거래량:
573.92K
Relative Volume:
0.21
시가총액:
$963.02K
수익:
$4.70M
순이익/손실:
$-4.99M
주가수익비율:
-0.0705
EPS:
-6.42
순현금흐름:
$-5.29M
1주 성능:
-18.58%
1개월 성능:
-33.23%
6개월 성능:
-72.06%
1년 성능:
-76.90%
1일 변동 폭
$0.4501
$0.48
1주일 범위
$0.4501
$0.59
52주 변동 폭
$0.4501
$7.20
Salarius Pharmaceuticals Inc Stock (SLRX) Company Profile
명칭
Salarius Pharmaceuticals Inc
전화
346-772-0346
주소
2450 HOLCOMBE BLVD, HOUSTON
SLRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SLRX
Salarius Pharmaceuticals Inc
|
0.4527 | 3.70M | 4.70M | -4.99M | -5.29M | -6.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.30 | 101.51B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.97 | 59.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.73 | 56.69B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
652.43 | 39.57B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
309.69 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Salarius Pharmaceuticals Inc Stock (SLRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-04-27 | 개시 | Ladenburg Thalmann | Buy |
Salarius Pharmaceuticals Inc 주식(SLRX)의 최신 뉴스
Technical signs of recovery in Salarius Pharmaceuticals Inc.Earnings Risk Report & High Yield Stock Recommendations - Newser
Advanced analytics toolkit walkthrough for Salarius Pharmaceuticals Inc.Market Risk Summary & Reliable Intraday Trade Alerts - Newser
How Salarius Pharmaceuticals Inc. stock performs during market volatilityDip Buying & Fast Gain Stock Tips - Newser
Salarius Pharmaceuticals To Implement 1-for-15 Reverse Stock Split - Nasdaq
Salarius Pharmaceuticals to implement 1-for-15 reverse stock split By Investing.com - Investing.com Australia
Salarius Pharmaceuticals announces 1-for-15 reverse stock split - MarketScreener
Salarius Pharmaceuticals Announces 1-for-15 Reverse Stock Split - GlobeNewswire
Salarius Pharmaceuticals Announces 1-For-15 Reverse Stock Split - TradingView
Cancer Drug Developer Salarius Launches Stock Consolidation to Meet Nasdaq Requirements - Stock Titan
What MACD and RSI say about Salarius Pharmaceuticals Inc.Rate Cut & Verified Momentum Watchlists - Newser
Is a relief rally coming for Salarius Pharmaceuticals Inc. holdersEarnings Recap Summary & AI Driven Stock Movement Reports - Newser
What analysts say about Salarius Pharmaceuticals Inc. stock outlookWeekly Trend Report & Safe Entry Point Identification - Newser
Salarius Pharmaceuticals Inc. stock prediction for this weekPortfolio Performance Summary & Smart Money Movement Tracker - Newser
Using data filters to optimize entry into Salarius Pharmaceuticals Inc.Portfolio Growth Summary & Expert Approved Momentum Ideas - Newser
Salarius Pharmaceuticals Q2 2023 Earnings Report | Financial OutlookNews and Statistics - IndexBox
Will Salarius Pharmaceuticals Inc. see short term momentumWeekly Trade Review & Trade Opportunity Analysis Reports - Newser
Salarius: Q2 Earnings Snapshot - New Haven Register
Why Salarius Pharmaceuticals Inc. is moving todayMarket Performance Summary & Proven Capital Preservation Tips - Newser
What’s next for Salarius Pharmaceuticals Inc. stock priceJuly 2025 Momentum & Weekly Breakout Stock Alerts - Newser
What’s next for Salarius Pharmaceuticals Inc. stock price [2025 Valuation Update]Stock Portfolio Risk Control - Newser
Market reaction to Salarius Pharmaceuticals Inc.’s recent news [Forecast Cut]Free Stepwise Trade Signal Implementation - Newser
Heatmap analysis for Salarius Pharmaceuticals Inc. and competitorsFree Optimized Watchlist With Daily Adjustments - Newser
Can Salarius Pharmaceuticals Inc. stock double in the next yearTop ROI Picks for Fast Gains - kangso.co.kr
Using flow based indicators on Salarius Pharmaceuticals Inc.Free Weekly Stock Opportunity Radar Scanner - Newser
How Efficient Is Salarius Pharmaceuticals Inc. at Controlling Operating CostsGrowth Summary Based on Market Positioning - Newser
Salarius Pharmaceuticals Inc (SLRX) Stock: A Comprehensive 52-Week Review - investchronicle.com
What makes Salarius Pharmaceuticals Inc. stock price move sharplyFree Consistent Income Focused Trade List - Newser
Salarius Pharmaceuticals Inc. Company’s Quarterly Earnings Growth: What the Numbers SayPattern Breakout Tracker with Screener Tools - Newser
Market reaction to Salarius Pharmaceuticals Inc.’s recent newsLong-Term Stock Growth Forecast Insights - Newser
Reversal indicators forming on Salarius Pharmaceuticals Inc. stockMarket Opportunity Tracker for Swing Traders - Newser
Signal strength of Salarius Pharmaceuticals Inc. stock in tech scannersSwing Trade Watchlist with Entry Zones - Newser
Published on: 2025-08-09 21:32:39 - Newser
Competitive Positioning of Salarius Pharmaceuticals Inc.: Is It Leading or LaggingFundamental Analysis for Value Stock Selection - Newser
Visualizing Salarius Pharmaceuticals Inc. stock with heatmapsFree Low Capital High Return Stock Plans - Newser
Salarius Pharmaceuticals Inc (SLRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.11%
1.56%
자본화:
|
볼륨(24시간):